References
- Atkins MB, Avigan DE, Bukowski RM, Childs RW, Dutcher JP, Eisen TG, et al. Innovations and challenges in renal cancer: consensus statement from the first international conference. Clin Cancer Res 2004; 10:6277S - 81S
- Deerwish IH, Tannebaum CS, Rayman PA, Finke JH. Mechanisms of immune dysfunction in renal cell carcinoma. Cancer Treat Res 2003; 116:29 - 51
- Kusmartsev S, Vieweg J. Enhancing efficacy of cancer vaccines in urologic oncology: new directions. Nature Reviews Urology 2009; 6:540 - 9
- Wang D, Dubois R. Eicosanoids and cancer. Nat Rev Cancer 2010; 10:181 - 93
- Greene ER, Huang S, Serhan CN, Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat 2011; 96:27 - 36
- Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. J Leukoc Biol 2010; 88:839 - 48
- Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells towards stable myeloid-derived suppressor cells. Blood 2011; 118:5498 - 505
- Kuhn H, O’Donnel VB. Inflammation and immune regulation by 12/15 lipoxygenases. Prog Lipid Res 2006; 45:334 - 56
- Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, et al. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res 2011; 71:6400 - 9
- Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006; 25:315 - 22